IDB Holland bv, your partner in nuclear medicineLutetium 177, radiopharmaceuticals and sources for nuclear medicine.
7 January 2016, Saint-Genis-Pouilly, France – Advanced Accelerator Applications S.A. (“AAA” or “the Company”) (Nasdaq: AAAP), an international specialist in Molecular Nuclear Medicine (“MNM”), announced today that it has acquired 100% of the shares of the IDB Group. The IDB Group includes IDB Holland bv, IDB Radiopharmacy bv and Beheermaatschappij Welde bv and is a leading manufacturer of Lutetium 177 (Lu-177). IDB produces, markets and sells Lu-177 under the brand name LuMark®, and has established this product as the leading brand of Lutetium 177 worldwide. LuMark® is the only Lu-177 product to have received European Marketing Authorization. >> read more
We are very proud to inform you that since the 19th of June 2015 LuMark Lu-177 chloride is registered in all EU memberstates, Norway, Iceland and Liechtenstein!>> read more
IDB Holland BV is a leading manufacturer of Lutetium 177 (Lu 177). Under the brand name of LuMark Lutetium 177 is being produced on a weekly basis. With daily shipments to destinations all over the world LuMark Lu 177 has already established itself as the leading brand of Lutetium 177. >> read more